Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.Unknown journal · 2026-05-25The emotional architecture of the psychedelic brain.Trends in cognitive sciences · 2025-10-31Neurocomputational evidence of sustained Self-Other mergence after psychedelicsmedRxiv · 2025-10-07Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use DisorderbioRxiv · 2025-07-17Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-14Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.Unknown journal · 2025-05-30Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-28Psychedelics Align Brain Activity with ContextbioRxiv · 2025-03-10A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-12Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.Unknown journal · 2024-12-03Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Unknown journal · 2023-12-14Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and PhenomenologybioRxiv · 2023-10-06Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.Unknown journal · 2023-01-29Neural mechanisms of psychedelic visual imagerymedRxiv · 2022-09-08Effective connectivity of emotion and cognition under psilocybinmedRxiv · 2022-09-08Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-06-30Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.Current topics in behavioral neurosciences · 2021-12-31Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.Frontiers in pharmacology · 2021-12-31Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral Cortex · 2021-10-31Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.Unknown journal · 2021-01-19Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.Unknown journal · 2020-11-29Neuropharmacological modulation of the aberrant bodily self through psychedelics.Neuroscience and biobehavioral reviews · 2019-12-31Psychedelics and music: neuroscience and therapeutic implications.International review of psychiatry (Abingdon, England) · 2018-07-31Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24Phenomenology, Structure, and Dynamic of Psychedelic States.Current topics in behavioral neurosciences · 2017-12-31LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07Effect of Psilocybin on Empathy and Moral Decision-Making.The International Journal of Neuropsychopharmacology · 2017-08-31Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-07-11Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.European Neuropsychopharmacology · 2016-01-21The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25